Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1

Interventions

Melphalan 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Etoposide 4Carboplatin 4Cyclophosphamide 3Busulfan 3Topotecan 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Ifosfamide 2sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1alvocidib 1Vincristine 1Thrombopoietin 1Thalidomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Mesna 1Maxitrol 1Cryotherapy 1Brachytherapy 1Bone Marrow Transplantation 1Biological Factors 1Anti-Infective Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Retinoblastoma × Maxitrol × Clear all
NCT02792036 2020-02-20

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 1 Completed
8 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡